- Siyoi said up to 120 cartons of assorted pharmaceuticals have been seized.
- He said enforcement operation took place between June 3 and June 7, 2024.
Image: FILE
The Pharmacy and Poisons Board has taken action against pharmaceuticals alleged to be operating illegally in Rift Valley.
The poisons board CEO F M Siyoi on Monday said the board's core responsibility is to regulate the practice of pharmacy and ensure the safety, quality, and efficacy of Medical Products and Health Technologies.
"In response to unlawful pharmaceutical activities in the Rift Valley region, the Board has undertaken a series of coordinated operations resulting in significant outcomes," Siyoi said.
The board CEO reported that more than 30 arrests have been made so far.
Siyoi said up to 120 cartons of assorted pharmaceuticals have been seized.
Additionally, more than 100 alleged rogue chemists have been closed due to the operations.
He said the closure of over 100 rogue pharmacies will help disrupt the illicit supply chain and prevent further harm to the public.
" The individuals who have been arrested are facing charges related to illegal distribution, sale and possession of pharmaceuticals," the board CEO said.
He noted that the decisive actions follow a comprehensive investigation into unlawful practices within the pharmaceutical industry.
This included the illegal sale of prescription medications, fraudulent activities involving government drugs, and unlicensed pharmaceutical distribution channels.
Siyoi said the board remains steadfast in its commitment to safeguarding public health and ensuring the integrity of the pharmaceutical supply chain.
" The proliferation of illicit pharmaceuticals poses a significant threat to public health and safety," he said.
He said the enforcement operation took place between June 3 and June 7, 2024, in collaboration with the National Police Service, targeting various locations known for their involvement in illegal pharmaceutical activities.
Siyoi said the board is committed to continue monitoring and enforcing compliance within the pharmaceutical industry by ensuring that, only safe and legitimate medications are available to the public.
" Consumers are urged to exercise caution when purchasing pharmaceuticals and to obtain medications only from licensed and reputable sources," he said.